Solange Sanches

Medical Oncologist at AC Camargo Cancer Center, Brazil #breastcancer #ovariancancer

[GBECAM @GBECAMConnect]

🇧🇷✨ Brazilian presentation 🇧🇷✨

Izabela Porto and co-authors: Body weight modification during adjuvant ovarian suppression for premenopausal women with luminal breast cancer in a Cancer Center in Brazil.

Happening today at #SABCS24 👀

@CescaGoldner @DraSSanches

[G Curigliano MD PhD @curijoey]

Check out the new guidelines that are going to be published or the St Gallen consensus

[Solange Sanches @DraSSanches]

@samiabomfim Meus sinceros sentimentos. Inacreditável o grau de insegurança de todos nós

[FabriceAndre @FAndreMD]

The 1st ⁦@myESMO⁩ guidelines on metastatic breast cancer have just been published with some important messages about the positioning of tdxd , palb2 mutations, alpelisib , IO and adc in tnbc... under the great leadership of Alessandra Gennari https://t.co/MIoR6XgBBw

[Solange Sanches @DraSSanches]

Inacreditável uma pessoa do nível do senador @ContaratoSenado ter que dedicar um tempo de seu impecável mandato para defender sua família. Já é passada a hora de se ter respeito com as pessoas

[TV Senado @tvsenado]

O senador @ContaratoSenado pediu a palavra para informar que o depoente à #CPIdaPandemia, Otávio Fakhoury, utilizou um tuíte do senador para publicar texto ofensivo à ele. O senador disse que irá apurar a responsabilidade por crime de homofobia. #CPIdaCovid #LGBTQia+

[Solange Sanches @DraSSanches]

@JavierCortesMD New era in TNBC !

[Javier Cortes MD PhD @JavierCortesMD]

Pembrolizumab improves OS in triple negative MBC. Terrific news for our patients today #breastcancer https://t.co/rJ3vYgeY9a

[Santhosh Ambika @RenoHemonc]

@stolaney1 @HassanSheikh_MD @OncoAlert Great news! https://t.co/NORvQPu29t

[Solange Sanches @DraSSanches]

Vote Now: I voted in the @ASCO election. Join me in casting your vote by December 8. https://t.co/xBbRd73J7M #ivoted via @ASCO_

[Solange Sanches @DraSSanches]

@PortalOnconews @acccancercenter Excelente, Douglas!

[FabriceAndre @FAndreMD]

Primary endpoint of 5 phase III randomized trials will be presented during @myESMO 2020, including 1st ADC in TNBC and 1st adjuvant trials testing cdk4/6 inh.